SYNTAX Score and SYNTAX Score II Can Predict the Clinical Outcomes of Patients with Left Main and/or 3-Vessel Disease Undergoing Percutaneous Coronary Intervention in the Contemporary Cobalt-Chromium Everolimus-Eluting Stent Era

समान संसाधन

• Very Late Pathological Responses to Cobalt–Chromium Everolimus‐Eluting, Stainless Steel Sirolimus‐Eluting, and Cobalt–Chromium Bare Metal Stents in Humans
  द्वारा: Mori, Hiroyoshi, और अन्य
  प्रकाशित: (2017)
• The Predictors of Target Lesion Revascularization and Rate of In-Stent Restenosis in the Second-Generation Drug-Eluting Stent Era
  द्वारा: Zheng, Chengbin, और अन्य
  प्रकाशित: (2019)
• One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial
  द्वारा: Natsuaki, Masahiro, और अन्य
  प्रकाशित: (2015)
• Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis
  द्वारा: Valgimigli, Marco, और अन्य
  प्रकाशित: (2014)
• A novel platinum chromium everolimus-eluting stent for the treatment of coronary artery disease
  द्वारा: Bennett, Johan, और अन्य
  प्रकाशित: (2013)